Publication | Open Access

Combined Therapy for Alzheimer’s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineSide EffectsNeuropharmacologyNeurochemical BiomarkersPharmacotherapyNeuroscienceNeurologyAging-associated DiseasePharmacologyTreatmentGeriatric Neurology